4 completed, 1 recruiting, 1 unknown. 6 Phase 2, 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 6 | Completed 4, Recruiting 1, Unknown 1 |
| Phase 3 | 3 | Completed 2, Recruiting 1 |
Follow Contrast Induced Nephropathy: new trials by email Literature Review of Contrast Induced Nephropathy trials Research Report on Contrast Induced Nephropathy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Remote Ischemic Preconditioning for Renal and Cardiac Protection in Congestive Heart Failure (RICH) Trial Remote ischemic preconditioning, Sham remote ischemic conditioning - Acute Kidney Injury, Heart Failure | Phase 2 / Phase 3 | Recruiting | VA Office of Research and Development | 240 | 2021-11-01 | 2025-12-15 |
| Comparison Between Effect of Acetazolamide and NaHco3 in Prevention of Contrast Nephropathy sodium bicarbonate, Acetazolamide, normal salin - Contrast Induced Nephropathy | Phase 2 | Completed | Shiraz University of Medical Sciences | 240 | 2007-09-01 | 2008-03-13 |
| Preventing Contrast Nephropathy With Sodium Bicarbonate in Patients With Pulmonary Edema,Heart Failure,Uncontrolled HTN Sodium Bicarbonate - Contrast Induced Nephropathy | Phase 2 | Completed | Tehran University of Medical Sciences | 72 | 2007-08-01 | 2008-11-26 |
| COmbined N-acetylcysteine and Bicarbonate in PCI To Reduce Adverse Side Effect of contrasT N-acetylcysteine, Sodium Bicarbonate - Contrast Induced Nephropathy | Phase 2 / Phase 3 | Completed | National University Hospital, Singapore | 477 | 2007-08-01 | 2014-01-14 |
| Prevention of Contrast Induced Nephropathy With Sodium Bicarbonate 3 amps of sodium bicarbonate mixed in one liter of D5W - Contrast Induced Nephropathy | Phase 2 | Unknown | Norton Community Hospital | 656 | 2006-11-01 | 2006-10-26 |
| N-Acetylcysteine in Critically Ill Patients Undergoing Contrast Enhanced Computed Tomography N-acetylcysteine, D5W Placebo - Contrast Induced Nephropathy, Critically Ill | Phase 2 / Phase 3 | Completed | Unity Health Toronto | 45 | 2002-08-01 | 2009-01-27 |
Acute Coronary Syndrome (1) · Acute Kidney Injury (1) · Coronary Artery Disease (1) · Critical Illness (1) · Heart Failure (1)
Arterial Occlusive Diseases (1) · Arteriosclerosis (1) · Cardiovascular Diseases (1) · Coronary Disease (1) · Disease Attributes (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Heart Diseases (1) · Kidney Diseases (1) · Male Urogenital Diseases (1) · Myocardial Ischemia (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Renal Insufficiency (1) · Urogenital Diseases (1)
Sodium Bicarbonate (3) · Acetylcysteine (2) · Acetazolamide (1)
National University Hospital, Singapore (1) · Norton Community Hospital (1) · Shiraz University of Medical Sciences (1) · Tehran University of Medical Sciences (1) · Unity Health Toronto (1) · VA Office of Research and Development (1)
Iran (2) · United States (2) · Canada (1) · Singapore (1)
Abbas Soleimani, M.D. (1) · Ahmad Iaminisharif, M.D. (1) · Akbar Fotuhi, M.D. (1) · Ali Farahani Vasheghani, M.D. (1) · Ali Kazemisaeid, M.D. (1) · Alireza Amirzadegan, M.D. (1) · Amir Hossein Razavi, M.D. (1) · Claudio M Martin, MD, FRCPC, MSc (1) · Donna S Sanders, DO (1) · Ebrahim Kassaian, M.D. (1) · Ebrahim Nematipur, M.D. (1) · Gelareh Sadigh, M.D. (1) · Gholamreza Davoodi, M.D. (1) · Hamidreza Purhosseini,, M.D. (1)
I01CX002045 (1)